2 results
Approved WMOCompleted
Primary objective: Determine whether treatment with a PI3K inhibitor (BYL719 or buparlisib) plus letrozole leads to an increase in pathologic response compared to treatment with placebo plus letrozole in patients with hormone receptor-positive HER2-…
Approved WMOCompleted
To compare, in a randomized controlled clinical trial, titanium and zirconia implants for the replacement of a single upper premolar after 1 and 3 years of function.